Acutus Medical, Inc.
Leading The Charge™️
Carlsbad, United States
87 employees
Post Ipo Debt
Total: $343.18M
Biotechnology, Health Care +2
General Information
Get notified when Acutus Medical, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Acutus Medical, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Acutus Medical, Inc.
Taxonomy: Cardiac arrhythmia, Medical technology, Electrophysiology, Healthcare innovation, CE Marked, FDA cleared, Arrhythmia care, Acutus Medical, Medical devices, Bioengineering, Private funding, Biomedical engineering, Atrial fibrillation, Medical innovation, Carlsbad
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | 1 | •••• •••• | 27 Apr 2022 |
| Series D | •••••• | 8 |
|
20 Jun 2019 |
| Debt Financing | •••••• | 3 |
|
20 Jun 2019 |
| Series C | •••••• | 5 |
|
22 Mar 2016 |
| Series B | •••••• | - | 30 Sep 2014 |
Acutus Medical, Inc. Alternatives & Competitors
You have to 'see' AF to treat AF.
Enhancing cardiac arrhythmia care and reducing cardiovascular disease costs with breakthrough soluti...
The future of cardiac pulsed field ablation
FAQ About Acutus Medical, Inc.
Don't just browse. Track.
Signal Tracker monitors Acutus Medical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
